Find financial news and analysis across NZ and Australia.
1 result for “aft.nz”
AFT Pharmaceuticals (AFT.NZ) enters its FY26 results period with a 39.69% annual gain and record half-year revenues. Technical indicators remain bullish with the price at NZ$3.66 trading above key moving averages.